Stay updated on ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.

Latest updates to the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision tag changed from v3.6.2 to v3.6.3, reflecting a small site-wide update in the page footer or metadata.SummaryDifference0.1%

- Check22 days agoChange DetectedA new revision entry v3.6.2 is added to the study record history and the older v3.6.0 entry is removed, indicating an update to the page's revision history.SummaryDifference0.1%

- Check36 days agoChange DetectedThe study history now shows that recruitment has ended for this trial. The revision history was updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.4%

- Check44 days agoChange DetectedThe record history now includes a new revision entry (v3.5.5) replacing the previous revision (v3.5.4), indicating a page version update.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page history now shows a new revision tag updated from v3.5.3 to v3.5.4, indicating a new site release for the page.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical trial record.SummaryDifference0.1%

Stay in the know with updates to ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.